Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2021-11-09 Regulatory Filings
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
KRTX and Zai Lab to Develop KarXT in Greater China
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number (8183R) and the date format typical of regulatory news service announcements. The content describes a strategic collaboration and licensing agreement between two entities (Karuna Therapeutics and Zai Lab), involving financial terms ($35 million upfront, milestones, royalties) related to a drug candidate (KarXT). This type of announcement, detailing a significant business transaction or partnership, is a form of regulatory disclosure. Since it is not a full annual report (10-K), an earnings release (ER), a proxy statement (DEF 14A), or a specific capital change (CAP/SHA), and it is a formal announcement published via RNS, it fits best under the general Regulatory Filings category (RNS) or potentially a specific transaction type. However, given the context of a broad business development announcement published through a regulatory feed, RNS is the most appropriate general classification for non-standard, mandatory disclosures. It is not an announcement of a report publication (RPA) because it contains the substance of the news, not just a notice that a report is available.
2021-11-09 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, PureTech Health plc, with the SEC. It includes a press release dated November 9, 2021, announcing participation at a healthcare conference and provides limited financial information as of September 30, 2021. The document is short (1770 characters) and primarily serves to furnish a press release rather than a full financial report. Form 6-K filings are typically used for current reports by foreign private issuers and often contain announcements or updates rather than comprehensive financial statements. Given the nature and length of the document, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories and includes current reports like Form 6-K.
2021-11-09 English
PRTC Presents at Jefferies Healthcare Conference
Regulatory Filings Classification · 100% confidence The document is identified by the RNS Number (7256R) and the header indicating it is distributed via RNS, the news service of the London Stock Exchange. The content announces the company's participation in an upcoming conference (Jefferies London Healthcare Conference) and provides a brief update on cash balances as of September 30, 2021. This type of announcement, which is a general regulatory update that doesn't fit into specific categories like Earnings Release (ER) or Capital Update (CAP), is best classified as a general Regulatory Filing (RNS). It is not a full report (like 10-K or IR), nor is it a specific announcement like a dividend (DIV) or director dealing (DIRS).
2021-11-09 English
New Research in Journal Nature on Gelesis Tech
Environmental & Social Information Classification · 99% confidence The document is an RNS (Regulatory News Service) announcement from PureTech Health PLC, dated November 1, 2021. The content primarily announces the publication of a scientific paper in Nature's Scientific Reports regarding the technology behind Gelesis's product, Plenity. It includes quotes, scientific details, product information, and importantly, a section titled 'Additional Information and Where to Find It' which references filings made with the SEC (Form S-4, proxy statement/prospectus) related to a business combination with a SPAC (Capstar). Since the core purpose of this specific document is to disseminate news about a scientific publication and related corporate activity via the RNS system, and it is not the full scientific paper, the full SEC filing (like S-4 or 10-K), or a dedicated earnings release, the most appropriate classification is Regulatory Filings (RNS), which serves as the general regulatory announcement category for non-standard filings.
2021-11-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the RNS Number (7936Q) and explicitly states it is providing information via RNS, the news service of the London Stock Exchange. The content details the 'Total Voting Rights and Share Capital' as of a specific month-end date (31 October 2021), referencing DTR 5.6.1. This type of mandatory disclosure regarding the total number of shares and voting rights is a standard regulatory announcement, often falling under general regulatory reporting or specific share/capital change notifications. Since it is a mandatory disclosure about the total share count, it fits best under the general 'Regulatory Filings' (RNS) category, as it is not a specific financial report (10-K, IR), a dividend notice (DIV), or a management change (MANG). While it relates to share capital, it is a disclosure of the current total, not an issuance or repurchase event (SHA/POS). Therefore, RNS is the most appropriate general regulatory filing code.
2021-11-01 English
Holdings in Company - TR-1 Correction Announcement
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: CORRECTION ANNOUNCEMENT' and 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership (major holdings) by individuals or entities, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it mentions RNS and the London Stock Exchange, the core content is a mandatory disclosure regarding shareholding thresholds being crossed or reached, making MRQ the most specific classification. The document length is moderate (5399 chars), but the content is the notification itself, not an announcement *about* a report.
2021-10-22 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.